RAPT
Rapt Therapeutics Inc
Price:  
8.05 
USD
Volume:  
19,412.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RAPT Relative Valuation

-1125.1%
Upside

As of 2025-07-07, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (82.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.05 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -1125.1%.

The range of the Relative Valuation is (63.18) - (114.91) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.7x - 18.7x 13.1x
Forward P/E multiples 10.3x - 21.3x 13.7x
Fair Price (63.18) - (114.91) (82.52)
Upside -884.9% - -1527.5% -1125.1%
8.05 USD
Stock Price
(82.52) USD
Fair Price

RAPT Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -1.31
2025-07-02 -1.30
2025-07-01 -1.19
2025-06-30 -1.30
2025-06-27 -1.37
2025-06-26 -1.58
2025-06-25 -1.55
2025-06-24 -1.33
2025-06-23 -1.21
2025-06-20 -1.21
2025-06-18 -1.20
2025-06-17 -1.27
2025-06-16 -1.34
2025-06-13 -1.35
2025-06-12 -1.42
2025-06-11 -1.43
2025-06-10 -1.55
2025-06-09 -1.56
2025-06-06 -1.52
2025-06-05 -1.33
2025-06-04 -1.33
2025-06-03 -1.28
2025-06-02 -1.22
2025-05-30 -1.15
2025-05-29 -1.21
2025-05-28 -1.26
2025-05-27 -1.27
2025-05-23 -1.60
2025-05-22 -1.11
2025-05-21 -1.15
2025-05-20 -1.25
2025-05-19 -1.26
2025-05-16 -1.09
2025-05-15 -1.05
2025-05-14 -0.97
2025-05-13 -0.97
2025-05-12 -1.14
2025-05-09 -0.98
2025-05-08 -1.04
2025-05-07 -1.04
2025-05-06 -1.05
2025-05-05 -1.19
2025-05-02 -1.26
2025-05-01 -1.19
2025-04-30 -1.20
2025-04-29 -1.18
2025-04-28 -1.20
2025-04-25 -1.14
2025-04-24 -1.14
2025-04-23 -1.12